Wörwag Pharma GmbH & Co. KG
Krupa Shah is a seasoned professional in regulatory affairs, currently serving as Senior Manager Regulatory Affairs at Wörwag Pharma GmbH & Co. KG since March 2020. With extensive experience in the field, Krupa has held various positions including Regulatory Affairs Manager at Medreich Limited and Sr Regulatory Specialist at PPD. Previous roles include Sr. Executive Regulatory Affairs at ELC Group and Regulatory Affairs Officer at both Astron Research Ltd Ahmedabad and Zydus Cadila, as well as at Troikaa Pharmaceuticals Ltd. Krupa Shah holds a degree in Pharmacy and Pharmaceutical Sciences from Rajiv Gandhi University of Health Sciences.
This person is not in any offices
Wörwag Pharma GmbH & Co. KG
Woerwag Pharma GmbH & Co. KG is a family-owned and international operating pharmaceutical company headquartered in Boeblingen, Germany, developing and selling biofactor preparations wordwide with more than 1400 employees in 35 countries. The company’s product rage is exclusively available in pharmacies and includes both prescription preparations as well as over the counter (OTC) products and food supplements. Therapeutic areas focus on diabetic comorbidities, diseases of the nervous system, of the musculoskeletal system, as well as on stabilizing the immune system.